The efficacy of anti‐IL‐1 targeted therapy in PAPA and PASH syndrome
Abstract Introduction Pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) and pyoderma gangrenosum, acne and hidradenitis suppurativa (PASH) are rare autoinflammatory diseases. Treatment of PAPA and PASH is difficult. Conventional immunosuppressants and tumor necrosis factor (TNF) antagonists f...
Main Authors: | Chloé Challamel, Céline Girard, Laurent Misery, Assia Touhouche, Marion Fradet, Maëlla Severino‐Freire, Cristina B. Livideanu, Maria P. Konstantinou, Fatma Jendoubi, Carle Paul |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-09-01
|
Series: | JEADV Clinical Practice |
Subjects: | |
Online Access: | https://doi.org/10.1002/jvc2.52 |
Similar Items
-
<i>PSTPIP1</i>-associated incomplete PAPA syndrome. Case report
by: Dali Sh. Macharadze, et al.
Published: (2022-11-01) -
Postoperative pyoderma gangrenosum after gunshot wound: A case report
by: Laura A. Valaas, et al.
Published: (2023-12-01) -
A case with pyoderma gangrenosum, after an abdominal surgery
by: Gulbahar Sarac, et al.
Published: (2019-06-01) -
Pyoderma gangrenosum with severe systemic features, after augmentation mammoplasty
by: Marine Beeckman, et al.
Published: (2024-03-01) -
Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome with recurrent vasculitis
by: Dorene Niv, DO, et al.
Published: (2017-01-01)